EDGAR Filing Documents for 0001193125-15-046688

Form SC 13G - Statement of Beneficial Ownership by Certain Investors:

SEC Accession No. 0001193125-15-046688

Filing Date

2015-02-12

Accepted

2015-02-12 16:03:59

Documents

Group Members

PONTIFAX (CAYMAN) II, L.P.PONTIFAX (ISRAEL) II, L.P.PONTIFAX (ISRAEL) II- INDIVIDUAL INVESTORS, L.P.PONTIFAX MANAGEMENT 2 G.P. (2007) LTD.PONTIFAX MANAGEMENT II L.P.

Document Format Files

Seq	Description	Document	Type	Size
1	SC 13G	d872991dsc13g.htm	SC 13G	100508
2	EX-99.1	d872991dex991.htm	EX-99.1	8423
	Complete submission text file	0001193125-15-046688.txt		110411

Mailing Address 2225 COLORADO AVENUE SANTA MONICA CA 90404

Business Address 2225 COLORADO AVENUE SANTA MONICA CA 90404 (310) 824-9999

Kite Pharma, Inc. (Subject) CIK: 0001510580 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G | Act: 34 | File No.: 005-88615 | Film No.: 15606071
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O KITE PHARMA, INC. 2225 COLORADO AVENUE SANTA MONICA CA 90404

Business Address

Nussbaum Ran (Filed by) CIK: 0001609805 (see all company filings)

Type: SC 13G